Answers are grounded in this paper and cite their sources.
Evaluates berberine-loaded nanoparticles' effects on liver damage in rats, suggesting a new protective strategy.
The liver performs essential functions critical to overall health. This study evaluated the efficacy of berberine-loaded albumin nanoparticles (BRB-BSA NPs) and cisplatin in mitigating hepatic damage caused by diethylnitrosamine (DEN) and carbon tetrachloride (CCl 4 ) in male albino rats . Molecular modeling was conducted to explore BRB interactions with Sirt1 , a NAD + -dependent protein deacetylase involved in key cellular pathways. BRB-BSA NPs showed superior results to cisplatin in reducing liver enzymes , oxidative stress, and proinflammatory markers while enhancing antioxidant activities . Cisplatin, however, was more effective in restoring mitochondrial pathway regulators. Additionally, BRB-BSA NPs improved liver tissue histoarchitecture and ultrastructure, bringing them closer to normal. In conclusion, BRB-BSA NPs demonstrated potent efficacy in alleviating DEN/CCl 4 -induced liver injury in male rats. • Hepatocellular carcinoma (HCC) remains a major global health challenge. • Molecular modeling shows berberine binds Sirt1 with high affinity, stabilizing key interactions. • Berberine-loaded albumin nanoparticles restore Sirt1 levels, promoting early liver protection. • The studied nanoparticles reversed most DEN/CCl4-induced liver histopathological changes.
No takes yet. Share an insight, caveat, or question.
Zaied et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: